Dr. Dobrosotskaya is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2215 Fuller Rd
Ann Arbor, MI 48105Phone+1 734-769-7100
Education & Training
University of MichiganFellowship, Hematology and Medical Oncology, 2009 - 2012
University of Texas Southwestern Medical CenterResidency, Internal Medicine, 2005 - 2008
Voronezh State Medical AcademyClass of 2000
Certifications & Licensure
MI State Medical License 2007 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Publications & Presentations
PubMed
- 29 citationsPhase I trial of oncolytic adenovirus-mediated cytotoxic and interleukin-12 gene therapy for the treatment of metastatic pancreatic cancer.Kenneth N. Barton, Farzan Siddiqui, Robert Pompa, Svend O. Freytag, Gazala Khan
Molecular Therapy Oncolytics. 2021-03-26 - 38 citationsMebendazole monotherapy and long-term disease control in metastatic adrenocortical carcinoma.Irina Dobrosotskaya, Gary D. Hammer, David E. Schteingart, Katherine E. Maturen, Francis P. Worden
Endocrine Practice. 2011-05-01 - 27 citationsA phase II study evaluating axitinib in patients with unresectable, recurrent or metastatic head and neck cancerPaul L. Swiecicki, Lili Zhao, Emily Belile, Assuntina G. Sacco, Douglas B. Chepeha
Investigational New Drugs. 2015-10-10
Professional Memberships
- Member
Other Languages
- Russian, Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
